This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Crossject. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Mind of Frédérique Flores-Ivanez
Introduction: Frédérique Flores-Ivanez, based in Ruffey les Beaune, France, is a notable inventor recognized for his contributions to pharmaceutical innovations. With a focus on creating effective treatment solutions, his work is pivotal in advancing medical therapies.
Latest Patents: Flores-Ivanez holds a patent for a pharmaceutical hydrocortisone solution designed for an injection device. This innovative solution comprises hydrocortisone or a pharmaceutically-acceptable salt thereof, rongalite, disodium EDTA, and a specific solvent. The patent details its application in treating acute adrenal insufficiency and asthma, highlighting its significance in emergency medical care. Additionally, it encompasses an injection kit that includes both the injection device and the pharmaceutical solution, enhancing usability for healthcare professionals.
Career Highlights: Currently employed at Crossject, Flores-Ivanez plays an integral role in the development of groundbreaking medical technologies. His work at the company demonstrates a commitment to improving patient outcomes through innovative healthcare solutions.
Collaborations: Throughout his career, Flores-Ivanez collaborates closely with his coworker, Pauline Bardonnaud. Together, they strive to push the boundaries of pharmaceutical research, promoting the creation of products that meet urgent medical needs.
Conclusion: Frédérique Flores-Ivanez exemplifies the spirit of innovation through his valuable contributions to the field of pharmaceuticals. His patent for a hydrocortisone injection solution not only represents a technological advancement but also showcases his dedication to addressing critical health issues. As he continues his work at Crossject, the potential for future innovations remains bright.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile